市場調查報告書
商品編碼
1470747
癌症資訊系統市場:按解決方案、服務、應用程式和最終用戶分類 - 全球預測 2024-2030Oncology Information Systems Market by Solutions, Service, Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年癌症資訊系統市場規模為88.5億美元,預計2024年將達到95.5億美元,2030年將達到156.7億美元,複合年成長率為8.50%。
癌症資訊系統 (OIS) 是專門專用平台,旨在管理與癌症治療相關的複雜資料和工作流程。癌症資訊系統為臨床醫生、腫瘤學家和醫療保健提供者提供了一套全面的工具,可以有效地規劃、管理和監測從診斷到生存的整個範圍內的癌症護理。癌症發病率的增加、對綜合衛生系統的重視以及對個人化醫療的需求不斷增加正在導致醫療保健基礎設施的擴張和市場採用率的提高。然而,對儲存和管理患者記錄時的資料安全和隱私的擔憂可能會阻礙市場成長。然而,用於腫瘤學專家之間的遠端存取和即時協作的基於雲端基礎的解決方案的加強,以及用於病人參與和即時監測的行動應用程式的開拓,為預期的市場成長提供了潛在的機會。
主要市場統計 | |
---|---|
基準年[2023] | 88.5億美元 |
預測年份 [2024] | 95.5億美元 |
預測年份 [2030] | 156.7億美元 |
複合年成長率(%) | 8.50% |
解決方案化療資訊系統的使用激增以減少用藥錯誤
先進的可視化和影像分析解決方案提供用於詳細解剖評估的高解析度影像和工具,用於需要精確診斷成像的複雜病例,例如腦腫瘤和胰腺癌,這對於腫瘤識別和表徵至關重要。近距離放射治療計劃系統是用於計劃內部放射治療的專用軟體,同時保留周圍的健康組織,這對於可以透過近距離放射治療治療的癌症(例如子宮頸癌和前列腺癌)至關重要。目標進行精確治療。臨床決策支援系統可幫助醫生根據患者病歷和科學指南等分析資料做出決策,並整合到所有腫瘤學實踐中,以確保使用基於證據的治療。臨床整合解決方案使各種腫瘤相關軟體系統能夠有效地通訊和交換資料,對於使用多個系統的醫療保健提供者至關重要。實驗室資訊系統是管理臨床實驗室業務的數位平台,對於經常進行臨床測試的癌症中心至關重要。腫瘤電子健康記錄(EHR) 系統旨在滿足腫瘤治療和患者管理的複雜需求,對於每個腫瘤實踐的全面患者記錄管理至關重要。影像儲存和通訊系統 (PACS) 和供應商中立存檔 (VNA) 系統可以在醫療保健系統之間安全地儲存和共用醫學影像,對於放射學和多中心實踐至關重要。人口健康管理是一種工具,旨在分析和管理跨人群的患者資料,以大規模改善醫療保健結果。輻射劑量管理 一種解決方案,旨在追蹤並最大程度地減少放射治療診所診斷和治療期間患者受到的輻射暴露。管理醫院和診所放射科的工作流程和病患資料的放射資訊系統。放射治療計劃系統是先進的軟體,為放射腫瘤科醫師提供規劃和模擬放射治療的工具,對於放射治療設施至關重要。治療管理系統和醫學影像分析系統涵蓋用於管理整個治療過程(從診斷到治療後追蹤)的各種系統,並包括用於醫學診斷的高級影像分析。治療計劃系統將多種治療方式和時間表整合為一個連貫的計劃,用於計劃複雜的癌症治療,並且是提供多模式癌症治療的設施所必需的。
應用癌症資訊系統在腫瘤外科的高階應用
腫瘤內科使用化療、荷爾蒙療法、生物療法和標靶治療來治療癌症。腫瘤醫學領域的 OIS 以患者管理系統為中心,該系統為管理患者病歷、用藥訂單、治療計劃和追蹤患者結果提供全面的解決方案。它們通常還包括臨床決策支援系統,以幫助腫瘤學家根據實證通訊協定選擇合適的化療方案。放射腫瘤學專注於消除癌細胞的放射線治療。用於放射腫瘤學的 OIS 通常包括治療計畫系統、劑量管理、影像導航放射治療(IGRT) 系統以及控制放射輸送的設備參數。此系統可確保精確的目標照射,同時最大限度地減少對周圍健康組織的損害。腫瘤外科涉及手術切除癌性腫瘤,通常輔以其他治療。在 OIS 中,腫瘤外科應用專注於術前計劃、手術導引、術後護理和手術干預記錄。這些應用程式可以與圖片存檔和通訊系統 (PACS) 以及電子健康記錄(EHR) 整合,以改善臨床工作流程。腫瘤外科需要仔細的治療計劃和協調。 OIS 有助於安排手術、追蹤患者復健情況並管理後續護理,這對於患者的持續護理非常有價值。
區域洞察
在美洲,癌症發生率上升、技術進步以及支持癌症研究的醫療改革的實施推動了對 OIS 的需求。先進的醫療基礎設施和較高的人均醫療費用造就了良好的市場環境。在加拿大,政府的措施和對癌症研究的資助正在推動 OIS 的採用。歐盟 (EU) 國家因其完善的醫療保健系統和積極參與癌症研究而對 OIS 表現出很高的需求。 《一般資料保護規範》(GDPR) 也影響 OIS 的開發和實施,以確保病患資料的安全和隱私。該地區普及對個人化醫療和綜合護理模式進行了大量投資。中東和非洲的 OIS 市場是一個新興市場,由於醫療保健支出的增加和基礎設施的發展,中東地區的採用速度正在加快。在非洲,由於資源限制,市場成長正在放緩,但經濟和醫療保健的逐步改善提供了長期商機。在亞太地區,特別是在中國和日本,政府在癌症控制、增加醫療保健支出和人口老化方面的舉措是推動 OIS 市場的關鍵因素。同時,由於癌症發病率上升和醫療基礎設施不斷改善,印度是一個快速成長的市場。
FPNV定位矩陣
FPNV定位矩陣對於評估癌症資訊系統市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對癌症資訊系統市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.癌症資訊系統市場的市場規模與預測是多少?
2.在癌症資訊系統市場的預測期間內,有哪些產品、細分市場、應用程式和領域需要考慮投資?
3.癌症資訊系統市場的技術趨勢和法規結構是什麼?
4.癌症資訊系統市場主要廠商的市場佔有率是多少?
5.進入癌症資訊系統市場的適當型態和策略手段是什麼?
[193 Pages Report] The Oncology Information Systems Market size was estimated at USD 8.85 billion in 2023 and expected to reach USD 9.55 billion in 2024, at a CAGR 8.50% to reach USD 15.67 billion by 2030.
Oncology Information Systems (OIS) are integrated, specialized platforms designed to manage the complex data and workflow processes associated with cancer treatment. Oncology Information systems provide a comprehensive suite of tools that assist clinicians, oncologists, and healthcare providers in efficiently planning, managing, and monitoring the entire cancer care continuum from diagnosis to survivorship. The growing prevalence of cancer, focus on integrated healthcare systems, and rising demand for personalized medicine expansion of healthcare infrastructure increase market adoption. However, concerns regarding data security and privacy in storing and managing patient records may impede market growth. Nevertheless, enhanced cloud-based solutions for remote access and real-time collaboration among oncology specialists and the development of mobile applications for patient engagement and real-time monitoring are expected to create potential opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.85 billion |
Estimated Year [2024] | USD 9.55 billion |
Forecast Year [2030] | USD 15.67 billion |
CAGR (%) | 8.50% |
Solutions: Burgeoning usage of chemotherapy information systems to reduce medication errors
Advanced Visualization & Image Analysis Solutions provide high-resolution images and tools for detailed anatomical assessments, crucial in identifying and characterizing tumors used in complex cases requiring precise imaging, such as brain or pancreatic cancer. Brachytherapy Treatment Planning Systems is software specializing in the planning of internal radiotherapy, allowing precision in the delivery of treatment to cancerous tissues while sparing surrounding healthy tissue, which is essential for cancers treatable with brachytherapy, such as cervical or prostate cancer. Clinical Decision Support Systems assist physicians in making decisions based on analytical data, such as patient history and scientific guidelines, and are used for all oncology practices to ensure evidence-based treatment. Clinical Integration solutions ensure that various oncology-related software systems can communicate and exchange data efficiently, which is essential for healthcare providers using multiple systems. Laboratory Information Systems is a digital platform that manages medical laboratory operations, crucial for cancer centers that conduct frequent lab tests. Oncology Electronic Medical Record (EHR) systems are designed to address the complex needs of oncology treatments and patient management, and they are integral for all oncology practices for comprehensive patient record-keeping. Picture Archiving & Communication System (PACS) & Vendor Neutral Archive (VNA) systems store and allow secure sharing of medical images across healthcare systems and are vital for radiology departments and multi-site practices. Population Health Management is a tool designed to analyze and manage patient data across a population to improve healthcare outcomes on a large scale. Radiation Dose Management Solutions aimed at tracking and minimizing radiation exposure to patients during diagnostic and therapeutic procedures for practices offering radiation therapy. Radiology Information Systems for managing workflow and patient data in the radiology department of a hospital or a clinic. Radiotherapy Treatment Planning Systems are advanced software that provides radiation oncologists with tools to plan and simulate radiotherapy treatment, essential for centers providing radiotherapy. Treatment Management Systems & Medical Image Analysis Systems encompass a range of systems used to manage the entire treatment process, from diagnosis through post-treatment follow-up, and include sophisticated image analysis for medical diagnosis. Treatment Planning Systems are used for planning complex cancer treatments, integrating multiple treatment modalities and schedules into a coherent plan, and are necessary for facilities that offer multi-modal cancer treatments.
Application: Evolving usage of oncology information systems for surgical oncology
Medical Oncology incorporates the use of chemotherapy, hormonal therapy, biological therapy, and targeted therapy to treat cancer. OIS in medical oncology is centered around the patient management system, providing a comprehensive solution for managing the patient's medical history, medication orders, treatment scheduling, and tracking of patient outcomes. It often includes clinical decision support systems to help oncologists choose the proper chemotherapy regimens based on evidence-based protocols. Radiation Oncology focuses on the administration of radiation therapy to eliminate cancer cells. OIS for radiation oncology typically features treatment planning systems, dose management, image-guided radiation therapy (IGRT) systems, and machine parameters controlling radiation delivery. The system ensures precise targeting, minimizing damage to surrounding healthy tissues. Surgical Oncology involves the surgical excision of cancerous tumors and is often complemented by other treatments. Within OIS, surgical oncology applications focus on preoperative planning, operative navigation, postoperative care, and the documentation of surgical interventions. They may integrate with picture archiving and communication systems (PACS) and electronic health records (EHR) for improved clinical workflows. Surgical oncology requires detailed planning and coordination of care. OIS aids in scheduling surgeries, tracking patient recovery, and managing follow-up care, which is highly beneficial for a patient's continuum of care.
Regional Insights
In the Americas, the demand for Oncology Information Systems (OIS) is driven by the increasing incidence of cancer, technological advancements, and the implementation of healthcare reforms supporting oncology research. Advanced healthcare infrastructure and high per capita healthcare expenditure contribute to a favorable market environment. In Canada, government initiatives and funding for cancer research support the adoption of OIS. European Union (EU) countries exhibit a high demand for OIS due to their well-established healthcare systems and active participation in cancer research. The General Data Protection Regulation (GDPR) has also influenced the development and implementation of OIS to ensure patient data security and privacy. Significant investments in personalized medicine and integrated care models are prevalent in the region. The OIS market in the Middle East and Africa is emerging, with the Middle East showing faster adoption due to increasing healthcare expenditure and infrastructure development. In Africa, the market growth is slower due to resource constraints; however, it presents a long-term opportunity with gradual economic and healthcare improvements. In the Asia-Pacific region, especially in China and Japan, government initiatives for cancer control, increasing healthcare expenditure, and the aging population are significant factors driving the OIS market. India, on the other hand, presents a rapidly growing market due to the rising incidence of cancer and ongoing improvements in healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Oncology Information Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oncology Information Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Oncology Information Systems Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Data Systems, Advanced Data Systems Corporation, Allscripts Healthcare Solutions, Inc., Altai AS, CureMD.com, Inc., DOSIsoft SA, Elekta AB, EndoSoft LLC, Epic Systems Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., International Business Machines Corporation, Karkinos Healthcare, Koninklijke Philips N.V., McKesson Corporation, MICA Information Systems, Inc., Oracle Corporation, RaySearch Laboratories, Siemens Healthineers AG, Sify Technologies, UnitedHealth Group Inc., and ViewRay Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Oncology Information Systems Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oncology Information Systems Market?
3. What are the technology trends and regulatory frameworks in the Oncology Information Systems Market?
4. What is the market share of the leading vendors in the Oncology Information Systems Market?
5. Which modes and strategic moves are suitable for entering the Oncology Information Systems Market?